Our Team
Henry Chen
BOARD MEMBER
Henry founded Delos Capital in 2015 and continues to serve as its managing partner, supporting life sciences leaders in turning bold ideas into medical breakthroughs. Previously, he was a partner and cohead of Asia at Permira and a managing director at Goldman Sachs, where he coled the General Industrials Group (Asia, excluding Japan). A former corporate finance attorney at Davis Polk, he also cofounded Curamir Therapeutics and Tulavi Therapeutics and currently serves as chairman and CEO of Tanvex Biopharma. Today, he brings this expertise to Averna Therapeutics as a board member.
He holds bachelor’s and master’s degrees from Harvard University and a JD from Harvard Law School.